{"id":"NCT01411137","sponsor":"Impax Laboratories, LLC","briefTitle":"Carbidopa-Levodopa (CD-LD) ER Alone or in Combination With CD-LD IR to IPX066 Followed by IPX066 Extension Safety Study","officialTitle":"An Open Label Conversion Study of Carbidopa-Levodopa (CD-LD) Extended-Release Taken Alone or in Combination With CD-LD Immediate Release to IPX066 Followed by an Open-Label Extension Safety Study of IPX066 in Advanced PD","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-08","primaryCompletion":"2013-03","completion":"2013-03","firstPosted":"2011-08-08","resultsPosted":"2017-04-18","lastUpdate":"2019-11-07"},"enrollment":43,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Parkinson's Disease"],"interventions":[{"type":"DRUG","name":"IPX066","otherNames":["ER CD-LD"]}],"arms":[{"label":"IPX066","type":"EXPERIMENTAL"}],"summary":"The study had three distinct parts and is described as follows:\n\nPart 1:\n\n* To evaluate the dose conversion from CD-LD ER taken alone or in combination with CD-LD IR to IPX066 in subjects with advanced PD\n* To evaluate the utility of the Objective Parkinson's Disease Measurement (OPDM), an exploratory computer-based system, in assessing dexterity and mobility in a subset of PD subjects.\n\nPart 2:\n\n• To evaluate the long-term safety and clinical utility of IPX066 under open-label conditions in eligible subjects who successfully completed Part 1 of the study.\n\nPart 3:\n\n• To further evaluate the long-term safety of IPX066 in eligible subjects who successfully completed Part 2.","primaryOutcome":{"measure":"Patient Global Impression (PGI)","timeFrame":"6 months","effectByArm":[{"arm":"Part 1: Conversion","deltaMin":5.2,"sd":1.35},{"arm":"Part 2: Open-Label Extension (Month 3)","deltaMin":5.4,"sd":1.3},{"arm":"Part 2: Open-Label Extension (Month 6)","deltaMin":5.3,"sd":1.49},{"arm":"Part 1 or 2 Early Termination","deltaMin":2.8,"sd":1.21}],"pValues":[]},"eligibility":{"minAge":"30 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":8,"countries":["United States"]},"refs":{"pmids":["28131167"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":43},"commonTop":["Upper Respiratory Infection","Nausea","Fall","Anxiety","Dyskinesia"]}}